Cervical cancer screening: on the way to a shift from cytology to full molecular screening (Q38180277)

30 August 2017

title

Cervical cancer screening: on the way to a shift from cytology to full molecular screening (English)

1 reference

30 August 2017

1 reference

cervix uterine cancer

1 reference

M G Dijkstra

1

1 reference

30 August 2017

P J F Snijders

2

1 reference

30 August 2017

M Arbyn

3

1 reference

30 August 2017

D C Rijkaart

4

1 reference

30 August 2017

J Berkhof

5

1 reference

30 August 2017

C J L M Meijer

6

1 reference

30 August 2017

language of work or name

1 reference

19 January 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

25

1 reference

30 August 2017

issue

5

1 reference

30 August 2017

page(s)

927-935

1 reference

Worldwide burden of cervical cancer in 2008.

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

The cervical cancer epidemic that screening has prevented in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Trends in cervical cancer in the Netherlands until 2007: has the bottom been reached?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

International incidence rates of invasive cervical cancer after introduction of cytological screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Trends of cervical cancer mortality in the member states of the European Union

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

How might HPV testing be integrated into cervical screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

A review of human carcinogens--Part B: biological agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Monitoring HPV16/18 immunisation in England and elsewhere.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Adolescent and young adult HPV vaccination in Australia: achievements and challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

The uptake of Human Papillomavirus (HPV) vaccine among adolescent females in the United States: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Human papillomavirus vaccine in adolescent women: a 2012 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Further analysis of the ARTISTIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

The health and economic effects of HPV DNA screening in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

HPV screening for cervical cancer in rural India

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Comparison of GP5+/6+-PCR and SPF10-line blot assays for detection of high-risk human papillomavirus in samples from women with normal cytology results who develop grade 3 cervical intraepithelial neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Methods for HPV detection in exfoliated cell and tissue specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Comparison of the clinical performance of PapilloCheck human papillomavirus detection with that of the GP5+/6+-PCR-enzyme immunoassay in population-based cervical screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Clinical validation of the cobas 4800 HPV test for cervical screening purposes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Nucleic acid tests for the detection of alpha human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Comparing the performance of six human papillomavirus tests in a screening population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Centrosome abnormalities and genomic instability by episomal expression of human papillomavirus type 16 in raft cultures of human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

The sensitivity and specificity of p16(INK4a) cytology vs HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL pap cytology results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Gene silencing in cancer in association with promoter hypermethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Sequential gene promoter methylation during HPV-induced cervical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Benefit of cervical screening at different ages: evidence from the UK audit of screening histories

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Comparison of type-specific human papillomavirus data from self and clinician directed sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT538

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDT538

1 reference

30 August 2017

1 reference